Episode 13: Butt-Out:Silencing “The Smoking Gun” in Health
In our 13th episode, we discuss smoking cessation. We present the impressive benefits in hard outcomes when people stop smoking. We then go through the list of interventions, from brief advice to the pharmaceutical options of nicotine replacement, two anti-depressants (Buproprion or Nortiriptyline) and the newest agent, Varenicline. Dosing, cessation rates and adverse events are reviewed (for medications, not cigarettes: that dose is zero).
Show Notes
1) Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease
2) Listening empathetically and asking if they are ready to quit smoking
3) Bupropion at a dose of 150 mg daily works as well as 300 mg daily
New Engl J Med 1997; 337:1195-202
4) Nortriptyline and bupropion for smoking cessation
Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1
5) Varenicline for smoking cessation
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
